CSTL vs EXPD · rev $187.2M vs P/E 26, rev $6.29B
Castle Biosciences Inc (CSTL) versus Expeditors International of Washington, Inc. (EXPD) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
Latest reported EXPD revenue for 2026-06-30 was $6.29B. Net income was $495.8M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
CSTL currently screens at market cap $570.2M. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Not investment advice. Open the CSTL and EXPD stock pages for the full models.
Not investment advice.